[Creatine phosphokinase in a hospitalized psychiatric population]. 1992

E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
Servicio de Psiquiatría General Varones, Hospital Psiquiátrico Zamudio, Vizcaya.

Creatine phosphokinase (CPK) is studied in psychiatric hospitalized patients under neuroleptic treatment in order to clarify the diagnostic value of this enzyme in the neuroleptic malignant syndrome (SNM). Intramuscular drug administration was, in the present study, the only variable associated with CPK levels over 1,000 U. Other items studied, like agitation, physical restraint or illness severity can not account for this elevation. In absence of i.m. medication, levels over 1,000 U must be carefully screened in order to rule out SNM or organic pathology associated.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007297 Inpatients Persons admitted to health facilities which provide board and room, for the purpose of observation, care, diagnosis or treatment. Inpatient
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009459 Neuroleptic Malignant Syndrome A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72) Neuroleptic-Induced Neuroleptic Malignant Syndrome,Neuroleptic-Malignant Syndrome, Neuroleptic Induced,NMS (Neuroleptic Malignant Syndrome),NMSs (Neuroleptic Malignant Syndrome),Neuroleptic Induced Neuroleptic Malignant Syndrome,Neuroleptic Malignant Syndrome, Neuroleptic Induced,Neuroleptic Malignant Syndromes,Syndrome, Neuroleptic Malignant,Syndromes, Neuroleptic Malignant
D011595 Psychomotor Agitation A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions. Agitation, Psychomotor,Akathisia,Excitement, Psychomotor,Restlessness,Psychomotor Hyperactivity,Psychomotor Restlessness,Hyperactivity, Psychomotor,Psychomotor Excitement,Restlessness, Psychomotor
D012149 Restraint, Physical Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION. Immobilization, Physical,Physical Restraint,Physical Immobilization,Physical Restraints,Restraints, Physical
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D006778 Hospitals, Psychiatric Special hospitals which provide care to the mentally ill patient. Mental Hospitals,Hospitals, Mental,Mental Institutions,Psychiatric Hospitals,Hospital, Mental,Hospital, Psychiatric,Institution, Mental,Institutions, Mental,Mental Hospital,Mental Institution,Psychiatric Hospital

Related Publications

E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
January 1974, The British journal of psychiatry : the journal of mental science,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
May 1973, The British journal of psychiatry : the journal of mental science,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
December 1980, Biological psychiatry,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
August 1974, The British journal of psychiatry : the journal of mental science,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
June 1976, Archives of general psychiatry,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
November 2009, The American journal of the medical sciences,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
October 1972, The British journal of psychiatry : the journal of mental science,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
January 1993, The American journal of medicine,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
November 1965, Ugeskrift for laeger,
E Manero Marcén, and P Malo Ocejo, and J J Uriarte Uriarte, and E Pinilla Tubet
June 1971, Archives of general psychiatry,
Copied contents to your clipboard!